0.5740
+0.0275
+(5.03%)
At close: April 17 at 8:26:11 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-175,709
-175,709
-192,606
-304,007
-412,660
Investing Cash Flow
142,570
142,570
139,564
365,835
202,777
Financing Cash Flow
42,118
42,118
30
1,508
36,238
End Cash Position
44,252
44,252
35,277
88,227
25,218
Income Tax Paid Supplemental Data
76
76
2,656
272
325
Capital Expenditure
-1,468
-1,468
-865
-5,676
-14,989
Repurchase of Capital Stock
-3,000
-3,000
--
--
--
Free Cash Flow
-177,177
-177,177
-193,471
-309,683
-427,649
12/31/2021 - 1/20/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4QK.SG Codexis Inc
1.8460
+1.65%
4QK.F Codexis, Inc.
1.8460
+0.65%
I5X.F Precigen, Inc.
1.1700
-2.42%
LEXXW Lexaria Bioscience Corp.
0.3400
-8.11%
CMPX Compass Therapeutics, Inc.
1.7500
+2.94%
LYRA Lyra Therapeutics, Inc.
0.0865
-5.98%
LXEO Lexeo Therapeutics, Inc.
2.7100
+18.86%
ALEC Alector, Inc.
0.9201
-5.95%
FGEN FibroGen, Inc.
0.2863
+3.13%
CRVS Corvus Pharmaceuticals, Inc.
3.2400
+0.31%